Tech
Posted By
Cameron On September 14, 2009 - 1:50pm

A new study by a University of Warwick researcher has demonstrated that researchers trying to model a range of processes could use the power and capabilities of a particular XBox chip as a much cheaper alternative to other forms of parallel processing hardware.
Posted By
News On September 14, 2009 - 1:30pm
Posted By
News On September 13, 2009 - 5:30pm

CHAMPAIGN, Ill. — Imagine a polka-dotted postage stamp that can sniff out poisonous gases or deadly toxins simply by changing colors.
Posted By
News On September 13, 2009 - 5:30pm

Imagine a polka-dotted postage stamp-sized sensor that can sniff out some known poisonous gases and toxins and show the results simply by changing colors.
Posted By
News On September 14, 2009 - 8:30pm
Scientists have found that laser therapy is equivalent to two different dosages of corticosteroid medications for treating vision loss from the blockage of small veins in the back of the eye, a condition known as branch retinal vein occlusion (BRVO). Furthermore, laser treatment was shown to have fewer complications for patients.
This research was part of the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study, a phase III clinical trial conducted at 84 sites and supported by the National Eye Institute (NEI) at the National Institutes of Health.
Posted By
News On September 14, 2009 - 8:30pm
Scientists have identified the first long-term, effective treatment to improve vision and reduce vision loss associated with blockage of large veins in the eye. This research was part of a multi-center, phase III clinical trial supported by the National Eye Institute (NEI) at the National Institutes of Health.
Posted By
Daniel On September 14, 2009 - 6:50pm
Treating second-degree burns with a nanoemulsion lotion sharply curbs bacterial growth and reduces inflammation that can otherwise jeopardize recovery, University of Michigan scientists have shown in initial laboratory studies.
U-M burn surgeon Mark R. Hemmila, M.D., reports today at the Interscience Conference for Antimicrobial Agents and Chemotherapy on results achieved with a nanoemulsion developed at U-M and licensed by U-M to Ann Arbor-based NanoBio Corporation.
Posted By
News On September 12, 2009 - 5:50pm
An existing osteoporosis drug is the first ever found to prevent cartilage loss from osteoarthritis following injury to a joint, and may also regenerate some cartilage that has been lost to osteoarthritis, according to an early study presented today at the annual meeting of the American Society for Bone and Mineral Research in Denver. While the study was in mice, the model closely mimics human osteoarthritis that develops following knee injuries, according to the study authors.
Posted By
News On September 11, 2009 - 5:30pm
Posted By
News On September 11, 2009 - 3:30pm